Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Ethical approval at 4 clinical sites

Posted on January 18, 2017December 19, 2018 by Wendy van Hemmen

You are required to login to view this page.




Lost your password?

This entry was posted in members. Bookmark the permalink.

Post navigation

← Site Initiation Visits
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. →

Recent Posts

  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
  • Cathelijne van der Wouden obtains PhD degree in pharmacogenetics
  • 2,500 patients enrolled in the PREPARE study since cross-over!
  • The 3rd U-PGx Personalized Medicine Public Day was successfully organized in Patras, Greece
  • Educating the Next Generation of Pharmacogenomics Experts
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.